A Taql polymorphism in the human interleukin‐1β (IL‐1β) gene correlates with IL‐1β secretion in vitro

European Journal of Clinical Investigation

Volumn 22, Issue 6, 1992, Pages 396-402

  POCIOT, F ^a   MOLVIG J ^a   WOGENSEN, L ^a   WORSAAE, H ^b   NERUP, J ^a  

^a HAGEDORN RESEARCH INSTITUTE   (Denmark)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Cytokines; IDDM; RFLP; susceptibility genes

Indexed keywords

INTERLEUKIN 1BETA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; HUMAN; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADOLESCENT; ADULT; ALLELES; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DIABETES MELLITUS, INSULIN-DEPENDENT; GENOTYPE; HUMAN; IN VITRO; INTERLEUKIN-1; MALE; MONOCYTES; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SUPPORT, NON-U.S. GOV'T;

EID: 0026652591     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.1992.tb01480.x     Document Type: Article

References (41)

1. Biology of interleukin 1
2. Interleukin‐1 and interleukin‐1 antagonism
3. Cytokines cause functional and structural damage to isolated islets of Langerhans
4. Mechanisms of pancreatic islet cell destruction. Dose‐dependent cytotoxic effect of soluble blood mononuclear cell mediators on isolated islets of Langerhans
5. Mechanisms of pancreatic β‐cell destruction in Type I diabetes
6. Cytotoxicity of human pl 7 interleukin‐1 pancreatic islets of Langerhans
7. Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxydative metabolism of isolated rat pancreatic islets
8. Interleukin‐1 inhibits glucose‐modulated insulin and glucagon secretion in rat islet monolayer cultures
9. Human tumor necrosis factor potentiates human interleukin 1‐mediated rat pancreatic β‐cell cytotoxicity
10. Interleukin‐1 induced impairment in pancreatic islets oxidative metabolism of glucose is potentiated by tumor necrosis factor
11. Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte‐activating factor (interleukin‐1)
12. Human interleukin 1 mediates cartilage matrix degradation
13. Interleukin‐1 affects the function of cultured human thyroid cells
14. 125I organisation and thyroid hormone release by interleukin‐1, tumor necrosis factor‐α, and interferon‐gamma in human thyrocytes in suspension culture
15. Interleukin 1 induces a shock‐like state in rabbits: Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition
16. The cytokine network
17. Participation of the cytokines interleukin 6, tumor necrosis factor‐alpha, and interleukin I‐beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control
18. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF)
19. Correlations and interactions in the production of interleukin‐6 (IL‐6), IL‐1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL‐6 suppresses IL‐1 and TNF
20. Monocyte function in IDDM patients and healthy individuals
21. A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin‐dependent diabetes mellitus
22. Platz P, Georgsen J, Jakobsen BK, Svjgaard A, Andersen V, Oxholm P, Karup Pedersen F, Friis J, Halberg P. NcoI Restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNFα) region in four autoimmune diseases
23. Increased plasma interleukin‐1 activity in women after ovulation
24. 2 shows stable interindividual differences
25. New, sensitive rocket immunoelectrophoretic assay for measurement of the reaction between endotoxin and Limulus amoebocyte lysate
26. Comparison of biological and immunologi‐cal activities of human monocyte‐derived interleukin 1β and human recombinant interleukin 1β
27. Cloning and expression of an interleukin‐1β precursor and its conversion to interleukin‐1β
28. A technique for radiolabelling DNA restriction endonuclease fragments to highly specific activity
29. Nuclsotide sequence of human monocyte interleukin 1 precursor cDNA
30. Cloning sequence and expression of two distinct human interleukin‐1 complementary DNAs
31. HUman interleukin‐1 beta gene
32. Site‐specific mutagenesis of the human interleukin‐1β gene: The role of arginine residue at the N‐termianl region
33. a point mutation uncouples human interleukin‐1β biological activity and receptor binding
34. Involvement of class II MHC molecules in the LPS‐induction of IL1/TNF secretions by human monocytes
35. Measurement of immunoreactive interleukin‐1β from human mononuclear cells: Optimization of recovery, intrasubject consistency, and comparition and inter‐leukin‐lα and tumor necrosis factor
36. Association between HLA‐DR2 and production of tumour necrosis factor α and interleukin 1 by mononuclear cells activated by lipopolysaccharide
37. Interleukin‐1 gene (IL 1) assigned to long arm of human chromosome 2
38. HLA associations insulin‐dependent diabetes: search doe heterogeneity in different groups of patients from a homogenous population
39. Genetic analysis of autoimmune type 1 diabetes mellitus in mice
40. Identification and mapping to chromosome 1 of a susceptibility locus for periinsuli‐tis in non‐obese diabetic mice
41. Type 1 diabetes in mice is linked to the interleukin‐1 receptor and LSH/Ity/Beg genes on chromosome 1